Jinlin Guo, Shan Wang, Mi Zhou, Jianghong Cao, Xinfeng Cai, Wenjun Zhang, Wei Zhao, Fang Zhang, Shuangshuang Tian, Xin Qian, Jingmin Zhang, Binbin Li
International journal of antimicrobial agents 2024 FebTigecycline has been widely used for multi-drug-resistant bacterial infections in China. Although many studies have reported the risk factors for tigecycline-induced hypofibrinogenaemia, it remains unknown whether valproic acid or voriconazole in combination with tigecycline is associated with the decrease in fibrinogen, as both drugs could lead to coagulation disorders. The aim of this study was to develop a nomogram for the prediction of tigecycline-induced hypofibrinogenaemia. This was a multi-centre retrospective case-control study. The primary outcome was the accurate prediction of tigecycline-induced hypofibrinogenaemia. Nomograms were developed from logistic regression models with least absolute shrinkage and selection operator regression for variable selection. Model performance was assessed via calibration plots, and models were validated internally using bootstrapping on a validation cohort. In total, 2362 patients were screened, of which 611 were eligible for inclusion in this study. These 611 patients were divided into the training cohort (n=488) and the validation cohort (n=123). Predictors included in the nomogram for the total population were total dose, age, fibrinogen, prothrombin time (PT), comorbidity, and concomitant use of voriconazole. Total dose, fibrinogen, PT, activated partial thromboplastin time, white blood cell count, and concomitant use of voriconazole were selected to predict hypofibrinogenaemia in patients with malignant haematologic diseases. Both models were calibrated adequately, and their predictions were correlated with the observed outcome. The cut-offs for treatment duration in the total population and the subgroup were 10 and 6 days, respectively. Tigecycline in combination with voriconazole could increase the risk of hypofibrinogenaemia, and tigecycline-induced hypofibrinogenaemia is more likely to occur in patients with malignant haematologic diseases. Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Jinlin Guo, Shan Wang, Mi Zhou, Jianghong Cao, Xinfeng Cai, Wenjun Zhang, Wei Zhao, Fang Zhang, Shuangshuang Tian, Xin Qian, Jingmin Zhang, Binbin Li. Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population. International journal of antimicrobial agents. 2024 Feb;63(2):107062
PMID: 38104947
View Full Text